Filter
385
Filtered Results: 385
Text search:
Ministry
of
Health
Ghana
National
Drugs
Programme
Featured
Recommendations
32
New Publications
102
Language
Document type
No document type
244
Studies & Reports
61
Guidelines
43
Manuals
24
Strategic & Response Plan
8
Training Material
2
Situation Updates
2
Fact sheets
1
Countries / Regions
Ghana
62
Sierra Leone
20
Africa
15
Nigeria
13
Global
13
Uganda
12
Kenya
12
Liberia
9
Malawi
8
Zambia
7
Guinea
5
Tanzania
5
South Africa
5
Burkina Faso
4
Ethiopia
4
Cameroon
4
Zimbabwe
4
Congo, Democratic Republic of
3
Nepal
3
Rwanda
3
Namibia
3
East and Southern Africa
3
West and Central Africa
3
Senegal
2
Mozambique
2
Benin
2
Ukraine
2
Botswana
2
South–East Asia Region
2
India
1
Cambodia
1
Eswatini/ Swaziland
1
Ecuador
1
Lesotho
1
Sri Lanka
1
Middle East and North Africa
1
Latin America and the Carribbean
1
Eastern Europe and Central Asia
1
Western and Central Europe
1
Asia
1
Laos
1
Russia
1
Gabon
1
Authors & Publishers
Publication Years
Category
Countries
147
Clinical Guidelines
37
Women & Child Health
22
Public Health
20
Key Resources
9
Capacity Building
6
Pharmacy & Technologies
6
Toolboxes
HIV
58
Mental Health
35
TB
22
AMR
19
Pharmacy
19
NTDs
14
Disability
11
Ebola
10
Caregiver
8
COVID-19
7
Rapid Response
5
Planetary Health
5
NCDs
4
Health Financing Toolbox
3
Polio
1
Refugee
1
Zika
1
Global Health Education
1
Social Ethics
1
Training in monitoring and epidemiological assessment of mass drug administration for eliminating lymphatic filariasis: learners’ guide. World Health Organization.
WHO practical guidelines. 2nd edition
These guidelines provide evidence-based guidance on the use of peripartum antiviral prophylaxis in HBsAg-positive pregnant women for the prevention of mother-to-child transmission ... HBV.
Prompt, effective antimalarial treatment, and supportive care can substantially reduce the rate of mortality from severe malaria. However, many children in malaria-endemic countries do not have access to h... facilities or a qualified health care provider and do not receive the necessary care in a timely fashion. Without rapid detection of danger signs and access to effective treatment, including pre-referral treatment that can be administered in the community level, many of these children with severe malaria die.
In situations where there is no immediate access to a health care facility, WHO recommends the administration of a standard dose of an effective antimalarial medicine as pre-referral treatment before referral to a facility at which complete treatment can be administered.
Rectal artesunate is the WHO-recommended pre-referral intervention in situations where artesunate injection are not feasible for children under the age of 6 years with suspected severe malaria. The intervention reduces the risk of death or permanent disability by up to 50% provided the child is referred to a health facility at which complete treatment can be administered.
This field guide is aimed at supporting the effective deployment of RAS as pre-referral treatment of suspected severe malaria in line with the WHO malaria guidelines.
Accessed March 14, 2017
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neuro...
A Technical Paper. Final Report
Guidance statement
Recommendations on contraceptive methods used by
women at high risk of HIV
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment ...
